Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• Age from 18 to 65 years.
• Both sexes.
• American Society of Anesthesiologists (ASA) physical status I or II.
• Undergoing supratentorial elective planned craniotomies.
Locations
Other Locations
Egypt
Ain Shams University
RECRUITING
Cairo
Contact Information
Primary
Omar A Khiralla, MBBCH
Omar-Ahmed@med.asu.edu.eg
00201095281838
Time Frame
Start Date: 2025-05-29
Estimated Completion Date: 2025-11-01
Participants
Target number of participants: 50
Treatments
Active_comparator: Group SB
Patients will receive a scalp block with bupivacaine alone.
Experimental: Group SD
Patients will receive a scalp block with dexmedetomidine as an adjuvant to bupivacaine.
Related Therapeutic Areas
Sponsors
Leads: Ain Shams University